Page 5 - நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய ஆரோக்கியம் அமைச்சகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய ஆரோக்கியம் அமைச்சகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய ஆரோக்கியம் அமைச்சகம் Today - Breaking & Trending Today

Russia starts testing Sputnik V vaccine on cancer patients — developer


Russia starts testing Sputnik V vaccine on cancer patients — developer
First experience demonstrates that no cancer disease can serve as a contraindication to the use of Sputnik V
MOSCOW, March 13. /TASS/. The tests of Russia’s Sputnik V anti-coronavirus vaccine on oncology patients have already begun, said Alexander Gintsburg, the director of the Gamaleya National Research Center for Epidemiology and Microbiology that developed Sputnik V.
In a separate development, the research [of Sputnik V vaccine] involving oncology patients has de-facto begun. The research is being carried out jointly with [chief non-resident oncologist of the Russian Healthcare Ministry] Andrei Dmitrievich Kaprin, he said in an interview on the Solovyev Live YouTube channel on Saturday. ....

Alexander Gintsburg , Andrei Dmitrievich Kaprin , Gamaleya Research Institute Of Epidemiology , Russian Healthcare Ministry , Microbiology Of The Russian Health Ministry , Gamaleya National Research Center , Solovyev Live Youtube , Gamaleya Research Institute , Russian Health , ரஷ்ய சுகாதாரம் அமைச்சகம் , நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய ஆரோக்கியம் அமைச்சகம் , ரஷ்ய ஆரோக்கியம் ,

Belarus to launch mass production of Sputnik V vaccine on March 30-31


8 Mar in 13:00
Belarus plans to launch mass production of the Sputnik V anti-coronavirus vaccine on March 30-31. A pilot batch is being examined by experts in Russia, Belarusian Deputy Health Minister Dmitry Cherednichenko said on Sunday, TASS reported.
The first batch, the so-called validation batch of 15,000 ampoules, was manufactured on February 26. Now it is being examined at the Russian Gamaleya Institute (the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry - TASS) for sustainability, efficacy, etc. We will begin to manufacture the vaccine from March 30-31. It is planned to make 500,000 doses a month, he said in an interview with the ONT television channel. ....

Dmitry Cherednichenko , Microbiology Of The Russian Health Ministry , Belarusian Deputy Health , Russian Gamaleya Institute , Gamaleya National Research Center , Russian Health Ministry , Chinese Sinopharm , நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய ஆரோக்கியம் அமைச்சகம் , ரஷ்ய ஆரோக்கியம் அமைச்சகம் ,